(Q38465808)

3 September 2017

title

Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters (English)

1 reference

3 September 2017

main subject

squamous cell carcinoma

1 reference

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

inferred from title

1 reference

Seung Hwan Moon

1

1 reference

3 September 2017

Joon Young Choi

2

1 reference

3 September 2017

Hwan Joo Lee

3

1 reference

3 September 2017

Young-Ik Son

4

1 reference

3 September 2017

Chung-Hwan Baek

5

1 reference

3 September 2017

Yong Chan Ahn

6

1 reference

3 September 2017

Keunchil Park

7

1 reference

3 September 2017

Kyung-Han Lee

8

1 reference

3 September 2017

Byung-Tae Kim

9

1 reference

3 September 2017

publication date

6 February 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

35

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

15-22

1 reference

Global cancer statistics, 2002

3 September 2017

cites work

1 reference

7 January 2021

1 reference

7 January 2021

Human papillomavirus genotype distribution in tonsil cancers

1 reference

7 January 2021

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

1 reference

7 January 2021

Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes

1 reference

7 January 2021

TNM staging of cancers of the head and neck: striving for uniformity among diversity.

1 reference

7 January 2021

Metabolic tumor burden predicts for disease progression and death in lung cancer.

1 reference

7 January 2021

Recommendations on the use of 18F-FDG PET in oncology

1 reference

7 January 2021

FDG-PET staging and importance of lymph node SUV in head and neck cancer

1 reference

7 January 2021

Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer

1 reference

7 January 2021

Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors

1 reference

7 January 2021

Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer

1 reference

7 January 2021

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

1 reference

7 January 2021

FDG-PET prediction of head and neck squamous cell cancer outcomes

1 reference

7 January 2021

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

1 reference

7 January 2021

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

1 reference

7 January 2021

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

1 reference

7 January 2021

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

1 reference

7 January 2021

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma

1 reference

7 January 2021

Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.

1 reference

7 January 2021

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

1 reference

7 January 2021

Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery

1 reference

7 January 2021

The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT.

1 reference

7 January 2021

18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma

1 reference

7 January 2021

Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications

1 reference

7 January 2021

Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology

1 reference

7 January 2021

CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma

1 reference

7 January 2021

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

7 January 2021

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

1 reference

7 January 2021

Time-dependent ROC curves for censored survival data and a diagnostic marker

1 reference

7 January 2021

Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers

1 reference

7 January 2021

Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA

1 reference

7 January 2021

Future of the TNM classification and staging system in head and neck cancer

1 reference

7 January 2021

A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer

1 reference

7 January 2021

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

1 reference

7 January 2021

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

1 reference

7 January 2021

Partial-volume effect in PET tumor imaging

1 reference

7 January 2021

Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer

1 reference

7 January 2021

Physiological FDG uptake in the palatine tonsils

1 reference

7 January 2021

Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.

1 reference

7 January 2021

Current management of tonsillar cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.22904

1 reference

release_7gfipzcbbrbddj2r64mwcupza4

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7gfipzcbbrbddj2r64mwcupza4

24 November 2022

mapped directly with Wikidata item

1 reference